# Study of LX4211 in Subjects With Type 2 Diabetes Mellitus

> **NCT00962065** · PHASE2 · COMPLETED · sponsor: **Lexicon Pharmaceuticals** · enrollment: 36 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** LX4211 Low Dose
- **DRUG:** LX4211 High Dose
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00962065
- **Lead sponsor:** Lexicon Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2009-12
- **Final completion:** —
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2011-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00962065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00962065, "Study of LX4211 in Subjects With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00962065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*